John O. Miners

The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism

Theresa H. Sullivan-Klose, Burhan I. Ghanayem, Douglas A. Bell et al. · Pharmacogenetics · 1996 · 586 citations

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni et al. · JAMA Oncology · 2019 · 335 citations · Full text

HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID

Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo et al. · Drug Metabolism and Disposition · 2004 · 333 citations

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

Wichittra Tassaneeyakul, Donald Birkett, M Veronese et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 317 citations

Interindividual Variability in Acetaminophen Glucuronidation by Human Liver Microsomes: Identification of Relevant Acetaminophen UDP-Glucuronosyltransferase Isoforms

Michael H. Court, Su Duan, Lisa L. von Moltke et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 301 citations